 The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. Fortress Biotech NASDAQ: FBIO creates partner companies to manage and optimize cancer immunotherapy and other disease treatment development programs. 